PlainRecalls
FDA Drug Low Class III Terminated

BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01

Reported: December 10, 2014 Initiated: September 24, 2014 #D-0289-2015

Product Description

BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01

Reason for Recall

Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.

Details

Units Affected
63,648 Bottles
Distribution
US Nationwide including Puerto Rico
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 63,648 Bottles.
Why was this product recalled?
Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 10, 2014. Severity: Low. Recall number: D-0289-2015.